A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.
3don MSN
A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...
Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...
The interim leader of the National Institutes of Health gave some clarification tied to Trump administrations restrictions on ...
The Trump administration directed federal health officials to pause external communications last week, which prompted the ...
The White House budget office rescinded the funding freeze, but Trump will still attempt to pull back funding from “woke” ...
Though Memoli is an NIH insider, one source familiar with him noted his perspectives —particularly his opposition to Covid-19 vaccine mandates — make him more of an outsider at the agency. In ...
Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...
Archbow Consulting announced Justine Hughes has been promoted to EVP of principal operations while Honora Gabriel and Rob ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback